zde bude asi časem úvaha
do čeho investovat krátkodobě - horizont 4-6 let
do čeho investovat dlouhodobě - horizont 15 - 25 let
ai bubble
https://trends.google.com/trends/explore?geo=US&q=ai%20bubble
ai bubble news
https://trends.google.com/trends/explore?geo=US&q=ai%20bubble%20news
michael burry ai bubble
michael burry ai bubble
the big short
new:
Sizable insider buy 500k shares $ASST from Chairman @ColeMacro as stock fell after $SMLR takeover approved. pic.twitter.com/12iUdoHnur
— matthew sigel, recovering CFA (@matthew_sigel) January 14, 2026
1/15/26 Portfolio Update:
— Jim Liu (@jiahanjimliu) January 16, 2026
97.75% $IREN
I trimmed other positions to heavily concentrate into IREN during the drip. There are alot of high flyers IBRX, ASTS, TE, SKYT recently but I am don't mind waiting patiently for IREN:
1. H5-10 Deal in Jan/Feb
2. SW1 Deal March/April
3.…
Danny tells us how to interpret his charts, and $NVDA #Nvidia Update!
Danny
patreon.com/DannyTrades
patreon.com/DannyTrades
or
nula je ledová
OdpovědětVymazatpři 20,65
0° = 49200
ale úplná je + 17500 (360) 66700 absolutní nula
nejvíce nad nulou listopad 2025 + 60,500
Strive *announced* intentions of becoming a Bitcoin treasury company on May 6th, 2025
OdpovědětVymazat255 days later, run a pubco $ASST, acquired another pubco $SMLR, launched a perpetual preferred equity $SATA AND now hold 12,797.9 Bitcoin.
https://x.com/PunterJeff/status/2012168999069761638
Immunitybio Inc - IBRX
OdpovědětVymazathttps://x.com/DrPatrick/status/2012239790444310895
What they do (ImmunityBio)
OdpovědětVymazatDevelops innovative immunotherapies and cell therapies to fight cancer and infectious diseases by boosting the body's immune response.
Their FDA-approved ANKTIVA® activates natural killer (NK) cells and T cells for long-lasting protection.
Investor & Financial Snapshot
Major institutional investors include Vanguard and BlackRock.
The company is working towards profitability but faces ongoing funding needs and execution risks.
https://www.sec.gov/Archives/edgar/data/1326110/000132611022000011/ibrx-20211231x10kexhibit211.htm
Infacell Therapeutics, Inc.
Inex Bio, Inc.
NantCell, Inc.
Etubics Corporation
Altor BioScience, LLC